I think a CR might be a bit pointless at this stage - they would be prudent to wait until a positive announcement on FDA approval. That would get some investor interest and the BIT could take advantage of a higher SP value.
Any FDA approval would indeed have to be released to the market so we can assume that this is still pending.
BIT Price at posting:
7.3¢ Sentiment: Hold Disclosure: Not Held
